![Active Biotech AB (publ) logo](/logos/ACTI.ST.webp)
Active Biotech AB (publ)
SSE:ACTI.ST
Overview | Financials
Company Name | Active Biotech AB (publ) |
Symbol | ACTI.ST |
Currency | SEK |
Price | 0.685 |
Market Cap | 259,210,850 |
Dividend Yield | 0% |
52-week-range | 0.401 - 1.478 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Helen Tuvesson Ph.D. |
Website | https://www.activebiotech.com |
An error occurred while fetching data.
About Active Biotech AB (publ)
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD